DCI
Data Collective IV Portfolio holdings
AUM
$130M
This Quarter Return
+1.18%
1 Year Return
+250.71%
3 Year Return
+278.3%
5 Year Return
–
10 Year Return
–
AUM
$93.8M
AUM Growth
+$93.8M
(-1.4%)
Cap. Flow
-$162K
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Roivant Sciences
ROIV
|
$162K |
| 2 |
EMBK
Embark Technology, Inc. Common Stock
EMBK
|
$3 |
Sector Composition
| 1 | Industrials | 47.86% |
| 2 | Healthcare | 42.6% |
| 3 | Technology | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Recursion Pharmaceuticals
RXRX
$2.02B
| $39.6M | 42.23% |
5,941,120
| – | – |
|
2
Evolv Technologies
EVLV
$1.37B
| $33.1M | 35.25% |
10,601,281
| – | – |
|
3
Rocket Lab Corporation Common Stock
RKLB
$21B
| $11.8M | 12.61% |
2,929,350
| – | – |
|
|
EMBK
4
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $8.95M | 9.54% |
3,186,007
-1
| -0% | -$3 |
|
5
MindMed
MNMD
$689M
| $318K | 0.34% |
100,350
| – | – |
|
|
6
Roivant Sciences
ROIV
$8.6B
| $28.6K | 0.03% |
3,875
-21,965
| -85% | -$162K |
|